(Q41883921)

English

The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study

scientific article published on 10 March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 October 2017

The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study (English)

1 reference

Europe PubMed Central

13 October 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

Carolyn F. Deacon

object named as

Carolyn F Deacon

7

0 references

Michael Camilleri

10

object named as

Michael Camilleri

1 reference

Europe PubMed Central

13 October 2017

author name string

Adrian Vella

1

1 reference

Europe PubMed Central

13 October 2017

Gerlies Bock

2

1 reference

Europe PubMed Central

13 October 2017

Paula D Giesler

3

1 reference

Europe PubMed Central

13 October 2017

Duane B Burton

4

1 reference

Europe PubMed Central

13 October 2017

Denise B Serra

5

1 reference

Europe PubMed Central

13 October 2017

Monica Ligueros Saylan

6

1 reference

Europe PubMed Central

13 October 2017

James E Foley

8

1 reference

Europe PubMed Central

13 October 2017

Robert A Rizza

9

1 reference

Europe PubMed Central

13 October 2017

publication date

10 March 2008

1 reference

Europe PubMed Central

13 October 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

13 October 2017

69

1 reference

Europe PubMed Central

13 October 2017

5

1 reference

Europe PubMed Central

13 October 2017

737-744

1 reference

Europe PubMed Central

13 October 2017

Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

Gastrointestinal regulation of food intake

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

Upper gastrointestinal function and glycemic control in diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

Glucagon-like peptide 1 and its derivatives in the treatment of diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

Inhibition of food intake in obese subjects by peptide YY3-36

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

Pancreatic polypeptide reduces appetite and food intake in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

Glucose-sensing in glucagon-like peptide-1-secreting cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

Natural substrates of dipeptidyl peptidase IV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

On the effects of glucagon-like peptide-1 on blood glucose regulation in normal and diabetic subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

Hyperglycemia affects proximal gastric motor and sensory function during small intestinal triglyceride infusion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

5 June 2018

Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

Gastric inhibitory polypeptide does not inhibit gastric emptying in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

Effects of glucagon-like peptide-1(7-36)amide on motility and sensation of the proximal stomach in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

18 August 2018

Proglucagon processing in porcine and human pancreas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898173

2 December 2018

Energy expenditure of nonexercise activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18331607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18331607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Performance characteristics of scintigraphic transit measurements for studies of experimental therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18331607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxyntomodulin suppresses appetite and reduces food intake in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/18331607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18331607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A patient questionnaire to identify bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18331607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoglycemia increases the gastric emptying rate in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/18331607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18331607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2265.2008.03235.X

1 reference

Europe PubMed Central

13 October 2017

1 reference

Europe PubMed Central

13 October 2017

1 reference

Europe PubMed Central

13 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41883921&oldid=1929361813"